Cite
HARVARD Citation
Takahara, N. et al. (2019). A feasibility study of gemcitabine, S-1 and leucovorin combination therapy (GSL) for advanced biliary tract cancer. Journal of chemotherapy. pp. 284-289. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Takahara, N. et al. (2019). A feasibility study of gemcitabine, S-1 and leucovorin combination therapy (GSL) for advanced biliary tract cancer. Journal of chemotherapy. pp. 284-289. [Online].